Skip to main content
Contact Us
Subscribe
E-Edition
72°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about 5/MeO/DMT
Recent news which mentions 5/MeO/DMT
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
March 28, 2024
Tickers
ATAI
NEWS
Tags
ATAI
Psychedelics
Benzinga
From
Benzinga
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
February 29, 2024
Tickers
GHRS
NEWS
Tags
Biotech
Market News
Cannabis
From
Benzinga
Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development
January 04, 2024
Tickers
ATAI
GHRS
NEWS
Tags
Psychedelics
Markets
ATAI
From
Benzinga
GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
November 14, 2023
Tickers
GHRS
Tags
financial results
Earnings
Psychedelic/Assisted Therapies
From
Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
October 02, 2023
Tickers
GHRS
Tags
News
5/MeO/DMT
FDA
From
Benzinga
GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
August 24, 2023
Tickers
GHRS
Tags
Cannabis
Market News
treatment/resistant depression
From
Benzinga
Harnessing The Power Of 5-MeO-DMT For Women Trauma Survivors: A Specialized Retreat
July 03, 2023
Tags
5/MeO/DMT
News
Trauma Survivors
From
Benzinga
All On Board For 5-MeO-DMT: This Retreat Hosts Expertly Guided Experiences For Women, BIPOC
July 02, 2023
Tags
Markets
Exclusives
Guidance
From
Benzinga
GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer
May 11, 2023
Tickers
GHRS
Tags
Psychedelic/Assisted Therapies
Earnings
Biotech
From
Benzinga
Beckley Psytech Begins Phase IIa Study Of Psychedelic Compound To Treat Depression
May 04, 2023
Tags
Markets
treatment/resistant depression
Beckley Psytech Ltd
From
Benzinga
UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
April 05, 2023
Tags
Psychedelics
Cannabis
Market News
From
Benzinga
2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products
January 11, 2023
Tickers
GHRS
PHRRF
Tags
GHRS
Benzinga
Psychedelics/Assisted Therapy
From
Benzinga
New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
December 29, 2022
Tickers
BMNDF
Tags
5/MeO/DMT
News
Benzinga
From
Benzinga
Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression
December 22, 2022
Tags
Markets
Cannabis
Psychedelics
From
Benzinga
Psychedelic Experiences: UCL Leads First-Ever Brain Imaging Study In Retreat Participants
December 07, 2022
Tags
F/I/V/E/
Tandava Retreats
Financing
From
Benzinga
Beyond Magic Mushrooms: Positive Clinical Trial For Treatment-Resistant Depression & Alcoholism
November 16, 2022
Tags
Markets
Psychedelics
Cannabis
From
Benzinga
Psychedelics Company's $60M Series A For Startup To Develop Treatment For Mental Health Disorders
November 02, 2022
Tags
5/MeO/DMT
News
Financing
From
Benzinga
Can Psychedelics Alleviate Prolonged Grief? Austin's Dell Med School Launches Clinical Trial To Find Out
October 18, 2022
Tags
Prolonged Grief
Markets
Cannabis
From
Benzinga
Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System
September 27, 2022
Tickers
BMNDF
Tags
Penny Stocks
Market News
Cannabis
From
Benzinga
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
September 23, 2022
Tickers
BMNDF
Tags
Benzinga
Psychedelics Therapy
5/MeO/DMT
From
Benzinga
DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results
August 29, 2022
Tickers
DMT
PSYBF
TRUFF
Tags
TRUFF
Cannabis
Market News
From
Benzinga
GH Research Shares Q2 2022 Financial Results & Business Updates
August 23, 2022
Tickers
GHRS
Tags
Markets
Psychedelics
GH001
From
Benzinga
Inside A 5-MeO-DMT Retreat: Who Should And Shouldn't Embark On This 'Hero's Journey'
February 12, 2022
Tickers
DMT
Tags
Psychedelic Retreats
Markets
psychedelics
From
Benzinga
5 Psychedelics For Mental Health
February 01, 2022
Tags
Ayahuasca
contributors
Psilocybin
From
Benzinga
Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT
January 24, 2022
Tags
Markets
psychedelics
Market News
From
Benzinga
A Deeper Look At DMT, The 'Spirit Molecule'
January 12, 2022
Tickers
DMT
Tags
DMT
5/MeO/DMT
contributors
From
Benzinga
GH Research Announces Positive Trial Results For Treatment-Resistant Depression
December 06, 2021
Tickers
GHRS
Tags
News
Topics
General
From
Benzinga
Mike Tyson: How A Drug Derived From Toad Venom Made Him Comfortable With Dying
November 16, 2021
Tickers
GHRS
Tags
Markets
MIke Tyson
Health Care
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.